Use of Influenza Antiviral Medications Among Outpatients at High Risk for Influenza-Associated Complications During the 2013–2014 Influenza Season
Author(s) -
Fiona P. Havers,
Brendan Flannery,
Jessie Clippard,
Manjusha Gaglani,
Richard K. Zimmerman,
Lisa A. Jackson,
Joshua G. Petrie,
Huong Q. McLean,
Mary Patricia Nowalk,
Michael L. Jackson,
Arnold S. Monto,
Edward A. Belongia,
Heather Eng,
Lois Lamerato,
Angela P. Campbell,
Alicia M. Fry
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ146
Subject(s) - medicine , influenza season , influenza like illness , antiviral treatment , flu season , emergency medicine , intensive care medicine , virus , virology , vaccination , influenza vaccine , chronic hepatitis
During the 2013-2014 influenza season, we analyzed data from 6004 outpatients aged ≥6 months with acute respiratory illness (ARI). Among the 2786 ARI patients at higher risk for influenza complications, 835 (30%) presented to care ≤2 days from symptom onset; among those, 126 (15%) were prescribed an antiviral medication.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom